biphasic insulin aspart 70

DRUG14 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy

Phase 1

Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects

CompletedNCT01520831

Novo Nordisk A/SDiabetes, Healthy

Start: 1999-04-30End: 2000-05-31Updated: 2017-01-04

Comparison of Two Formulations of Biphasic Insulin Aspart 70

CompletedNCT01523041

Novo Nordisk A/SDiabetes, Healthy

Start: 1999-11-03End: 1999-11-30Updated: 2017-02-24

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

CompletedNCT01524809

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2001-01-31End: 2001-06-30Updated: 2017-01-05

Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

CompletedNCT01526941

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2001-05-31End: 2001-07-31Updated: 2017-01-05

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects

CompletedNCT01527656

Novo Nordisk A/SDiabetes, Healthy

Start: 2003-12-31End: 2004-02-29Updated: 2017-01-06

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects

CompletedNCT01527565

Novo Nordisk A/SDiabetes, Healthy

Start: 2003-01-20End: 2003-02-26Updated: 2017-02-24

Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

CompletedNCT01536028

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2006-04-30End: 2006-07-31Updated: 2017-01-06

Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers

CompletedNCT01538511

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2006-06-05End: 2007-03-13Updated: 2017-10-06

Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

CompletedNCT01620333

Novo Nordisk A/SDiabetes, Healthy

Start: 2000-02-29End: 2000-04-30Updated: 2017-01-05

Phase 2

Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

CompletedNCT01526980

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2002-05-31End: 2002-11-30Updated: 2017-01-05

Phase 3

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

CompletedNCT01520818

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2000-03-31End: 2001-04-30Updated: 2017-01-04

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

CompletedNCT01520753

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 1999-03-31End: 1999-06-30Updated: 2017-01-04

Unknown Phase

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

CompletedNCT00775736

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2008-10-31End: 2011-01-31Updated: 2017-01-11

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

CompletedNCT00834262

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2009-04-30End: 2010-02-28Updated: 2016-10-31

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01